From April 1, 2022 to June 30, 2022, the company has repurchased 2,932,610 shares, representing 0.5% for CNY 132.62 million. With this, the company has completed the repurchase of 4,416,310 shares, representing 0.75% for CNY 205.11 million under the buyback announced on March 19, 2022.
Autobio Diagnostics Co., Ltd.
Equities
603658
CNE100002GC4
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
56.35 CNY | +0.21% | +3.81% | -1.16% |
04-19 | Autobio Diagnostics' Q1 Profit Jumps 34% | MT |
04-19 | Autobio Diagnostics' 2023 Profit Climbs 4% as Operating Income Stays Flat | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.16% | 4.51B | |
+0.89% | 12.8B | |
-10.29% | 7.61B | |
+5.74% | 4.49B | |
-50.70% | 3.3B | |
+12.21% | 2.73B | |
-16.13% | 2.02B | |
-11.50% | 1.73B | |
-5.02% | 1.64B | |
-8.80% | 1.53B |
- Stock Market
- Equities
- 603658 Stock
- News Autobio Diagnostics Co., Ltd.
- Tranche Update on Autobio Diagnostics Co., Ltd.'s Equity Buyback Plan announced on March 19, 2022.